1. Ferlay, J, Soerjomataram, I, Dikshit, R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359-E386. doi:10.1002/ijc.29210
Google Scholar | Crossref | Medline2. NCCN . NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ®) Colon Cancer. Continue NCCN.Org NCCN Guidelines for Patients ®. www.Nccn.Org/Patients. 2019.
Google Scholar3. NCCN . NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ®) Rectal Cancer. Continue NCCN.Org NCCN Guidelines for Patients ®. www.Nccn.Org/Patients. 2019.
Google Scholar4. Boakye, D, Jansen, L, Halama, N, et al. Discontinuation and dose reduction of adjuvant chemotherapy in stage III colon cancer patients. Ther Adv Med Oncol. 2021;13:17588359211006348. doi:10.1177/17588359211006348
Google Scholar | SAGE Journals5. Dobie, SA, Baldwin, LM, Dominitz, JA, et al. Completion of therapy by Medicare patients with stage III colon cancer. J Natl Cancer Inst. 2006;98(9). doi:10.1093/jnci/djj159
Google Scholar | Crossref6. Luo, R, Giordano, SH, Freeman, JL, et al. Referral to medical oncology: a crucial step in the treatment of older patients with stage III colon cancer. Oncologist. 2006;11(9):1025-1033. doi:10.1634/theoncologist.11-9-1025
Google Scholar | Crossref7. Sargent, D, Sobrero, A, Grothey, A, et al. Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials. J Clin Oncol. 2009;27(6):872-877. doi:10.1200/JCO.2008.19.5362
Google Scholar | Crossref | Medline8. Neugut, AI, Matasar, M, Wang, X, et al. Duration of adjuvant chemotherapy for colon cancer and survival among the elderly. J Clin Oncol. 2006;24(15):2368-2375. doi:10.1200/JCO.2005.04.5005
Google Scholar | Crossref9. Sarfati, D, Koczwara, B, Jackson, C. The impact of comorbidity on cancer and its treatment. CA Cancer J Clin. 2016;66(4):337-350. doi:10.3322/caac.21342
Google Scholar | Crossref | Medline10. Vaz-Luis, I, Keating, NL, Lin, NU, et al. Duration and toxicity of adjuvant trastuzumab in older patients with early-stage breast cancer: a population-based study. J Clin Oncol. 2014;32(9):927-934. doi:10.1200/JCO.2013.51.1261
Google Scholar | Crossref | Medline11. Williams, GR, Mackenzie, A, Magnuson, A, et al. Comorbidity in older adults with cancer. J Geriatr Oncol. 2016;7(4):249-257. doi:10.1016/j.jgo.2015.12.002
Google Scholar | Crossref12. Klepin, HD, Pitcher, BN, Ballman, KV, et al. Comorbidity, chemotherapy toxicity, and outcomes among older women receiving adjuvant chemotherapy for breast cancer on a clinical trial: CALGB 49907 and CALGB 361004 (alliance). J Oncol Pract. 2014;10(5):e285. doi:10.1200/JOP.2014.001388
Google Scholar | Crossref | Medline13. Zhao, J, Mao, Z, Fedewa, SA, et al. The affordable care act and access to care across the cancer control continuum: a review at 10 years. CA Cancer J Clin. 2020;70(3):165-181. doi:10.3322/caac.21604
Google Scholar | Crossref14. Parikh, RR, Grossbard, ML, Green, BL, et al. Disparities in survival by insurance status in patients with Hodgkin lymphoma. Cancer. 2015;121(19):3515-3524. doi:10.1002/cncr.29518
Google Scholar | Crossref | Medline15. Mesquita-Neto, JWB, Cmorej, P, Mouzaihem, H, et al. Disparities in access to cancer surgery after medicaid expansion. 2019;219(1):181-184. doi:10.1016/j.amjsurg.2019.06.023
Google Scholar | Crossref